http://web.archive.org/web/20120309193850id_/http://edition.cnn.com:80/2012/01/08/health/novartis-drug-recall/index.html?

-- pharmaceutical company @entity1 on sunday voluntarily recalled a number of over-the - counter drugs -- including certain bottles of @entity5 and @entity6 -- because of complaints about mislabeled and broken pills			1
the @entity10 - based company said on its website that " there have been no related adverse ( health ) events " related to the problems			0
at the same time , it urged @entity18 consumers to " either destroy or return unused " products that are part of the recall			2
the items involved in the voluntary recall include @entity5 and @entity25 products with expiration dates of december 20 , 2014 , or earlier , as well as @entity6 and @entity27 products with december 20 , 2013 , or earlier expiration dates			1
" ( @entity1 ) is taking this action as a precautionary measure , because the products may contain stray tablets , capsules or caplets from other @entity1 products , or contain broken or chipped pills , " the company said			1
the moves follows @entity1 ' decision to suspend operations at , and shipments from , its @entity44 , @entity45 , facility			0
the company said this was done " to accelerate maintenance " and make other improvements , adding that it currently " is not possible " to determine when the plant will reopen			0
agencies : no need for baby formula recall while @entity1 announced sunday 's recall , it said that it did so " with the knowledge of the @entity56			2
" this came about after an internal review and assessment of complaints identifying " issues such as broken gelcaps , chipped tablets and inconsistent bottle packaging			1
" in its news release , @entity1 said that the recall and processing upgrades would cost an estimated $ 120 million , which will be assessed in the fourth quarter of 2011			1
the number of pills affected by the recall was not released			0
more information will be announced monday , @entity1 said			0
for a list of products associated with the recall , please go to : @entity76			0

@entity5 and @entity6 products are part of the voluntary recall
@entity1 says " stray " pills " from other @entity1 products " *put* in the *wrong* package
an internal probe also found evidence of " broken gelcaps ( and ) chipped tablets "
the recall and processing upgrades will cost $ 120 million , @entity1 estimates

@entity1:Novartis
@entity0:CNN
@entity6:Bufferin
@entity5:Excedrin
@entity25:NoDoz
@entity10:Switzerland
@entity18:U.S.
@entity44:Lincoln
@entity45:Nebraska
@entity56:U.S. Food and Drug Administration
@entity76:http://www.novartis-otc.com/otc/index.html
@entity27:Gas-X Prevention